Diagnostics Excellence Reinforce partnerships with physicians and healthcare facilities by highlighting Precision Pathology Services’ rapid turnaround times, meticulous two-pathologist review plus third-party expert arbitration, and secure HIPAA-compliant online reporting to support efficient patient care and reliable diagnoses.

Acquisition History Note the recent asset sale to bioAffinity Technologies and prior licensing of CyPath Lung as an LDT, signaling openness to collaboration, technology transfer, and strategic partnerships that could expand service offerings or co-developed diagnostic tests.

LDT Capability Position opportunities around laboratory-developed tests and advanced pathology workflows, leveraging the CyPath Lung background to explore co-development, validation studies, or expanded panels for early lung cancer detection.

Market Presence Leverage their San Antonio base and established reputation for high-quality, fast pathology services to offer regional expansion, referral networks, and enterprise-wide pathology outsourcing opportunities for multi-site health systems.

Financial Footprint Target mid-market hospitals and clinics with scalable pathology partnerships given a defined revenue range and lean team size, offering cost-effective outsourcing, managed services, or shared revenue models aligned with their current capacity.